Vaxxa Past Earnings Performance

Past criteria checks 3/6

Vaxxa's earnings have been declining at an average annual rate of -18.7%, while the Entertainment industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 73.2% per year. Vaxxa's return on equity is 1.6%, and it has net margins of 0.3%.

Key information

-18.7%

Earnings growth rate

60.0%

EPS growth rate

Entertainment Industry Growth38.5%
Revenue growth rate73.2%
Return on equity1.6%
Net Margin0.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Vaxxa makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:VAXXA Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2492060
30 Jun 2480-160
31 Mar 2468-260
31 Dec 2354-550
30 Sep 23-4-3210
30 Jun 23-2-3810
31 Mar 231-4220
31 Dec 220-4220
30 Sep 2232-2250
30 Jun 2221-1750
31 Mar 229-1450
31 Dec 215-1360
30 Sep 214-750
30 Jun 213-860
31 Mar 211-750
31 Dec 201-640
30 Sep 201-540
30 Jun 201-430
31 Mar 201-530
31 Dec 191-530
30 Sep 191-630
30 Jun 192-530
31 Mar 192-530
31 Dec 183-430
30 Sep 183-430
30 Jun 184-430
31 Mar 184-430
31 Dec 174-440
30 Sep 174-330
31 Dec 161-120

Quality Earnings: VAXXA has high quality earnings.

Growing Profit Margin: VAXXA became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VAXXA has become profitable over the past 5 years, growing earnings by -18.7% per year.

Accelerating Growth: VAXXA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: VAXXA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Entertainment industry (-41.6%).


Return on Equity

High ROE: VAXXA's Return on Equity (1.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 19:06
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vaxxa AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution